ClinicalTrials.gg
RecruitingNCT07889583ACROMIALUpdated Oct 22, 2026

Acromial Morphology: Reliability of CT-based Assessment and Relationship With Age in a Series of 420 Patients

An observational study in Shoulder Impingement Syndrome and Acromial Morphology, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 20 Years to 98 Years. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by University Hospital, Strasbourg, France · Observational

From the registry’s dates

  • Started Jan 2026; still recruiting 9 months later.
Updated Oct 22, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
420
Ages
20 Years to 98 Years
Sex
All
01

Study summary

This study evaluates the reliability of CT-based assessment of acromial morphology and its relationship with age, in order to improve understanding of shoulder pathologies such as subacromial impingement and rotator cuff tears.

Read the detailed description

This is a retrospective monocentric observational study conducted at Strasbourg University Hospitals including 420 patients who underwent shoulder CT or arthro-CT between 2009 and 2023. Acromial morphology is assessed using the Bigliani classification on 3D reconstructions. The study evaluates intra- and inter-observer reliability using kappa coefficients and explores the relationship between acromial shape and patient age. Data are collected retrospectively from medical records and imaging software, with repeated assessments performed at 3 and 6 months to evaluate reproducibility.

02

Conditions studied

  • Shoulder Impingement Syndrome
  • Acromial Morphology

Keywords

  • Acromion
  • Shoulder impingement
  • Computed tomography
03

In context

Shoulder Impingement Syndrome

312 studies on the registry are indexed under Shoulder Impingement Syndrome; 58 are open to participants now.

This study's planned enrollment of 420 is above the median of 60 across 41 observational studies indexed under Shoulder Impingement Syndrome.

Browse Shoulder Impingement Syndrome studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 989 studies on the registry; 348 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 98 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who underwent shoulder CT or arthro-CT at Strasbourg University Hospitals between 2009 and 2023, stratified by age groups, and included for analysis of acromial morphology.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subjects aged 20 to 89 years
  • Shoulder CT or arthro-CT performed at Strasbourg University Hospitals
  • Examination performed between 02/01/2009 and 11/12/2023
  • Independent indication for imaging
  • No documented opposition to reuse of medical data for research

Exclusion criteria

Exclusion Criteria:

  • Imaging not performed
  • Poor image quality
  • Inability to perform 3D reconstruction
  • Duplicate examination within the same age group
  • History of acromial fracture
  • Previous surgery interfering with acromial analysis (arthroplasty, acromioplasty, osteosynthesis, arthrodesis)
  • Shoulder pathology interfering with acromial analysis (severe acromioclavicular arthropathy, humeral head osteonecrosis, glenohumeral dysplasia)
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
420 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Intra-Rater and Inter-Rater Reliability of the Bigliani Classification of Acromial Morphology

    Acromial morphology will be classified as Type I (flat), Type II (curved), or Type III (hooked) according to the Bigliani classification, using 3D-reconstructed shoulder CT scans or CT arthrography images. Intra-rater and inter-rater reliability will be assessed using kappa agreement coefficients (Cohen's kappa and Fleiss' kappa). Five evaluators will assess the images, with repeat evaluations at 3 and 6 months after the initial assessment.

    Time frame: Initial assessment, with repeat assessments at 3 and 6 months after the initial assessment.

07

Study locations

1 of 1 sites recruiting
  • Service de Chirurgie Orthopédique du Membre Supérieur - CHU de Strasbourg - France
    Strasbourg, 67091, France
    • Philippe CLAVERT, MD, PhD · Contact · philippe.clavert@chru-strasbourg.fr · 33 3 88 11 67 68
    • Philippe CLAVERT, CLAVERT · Principal investigator
    • Yohan GAGNARD, MD · Sub investigator
    • Nicolas MEYER, MD, PhD · Principal investigator
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2026 (actual). Primary completion is estimated for Nov 2026, 10 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2026
First posted
Oct 22, 2026
StartActual
Jan 22, 2026
Primary completionEst.
Nov 22, 2026
CompletionEst.
Jan 22, 2027
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07889583
Responsible party
Sponsor
First posted
Oct 22, 2026
Start date
Jan 22, 2026
Primary completion
Nov 22, 2026 (estimated)
Completion
Jan 22, 2027 (estimated)
Last update
Oct 22, 2026

Study contacts

Philippe CLAVERT, MD, PhD
Contact
philippe.clavert@chru-strasbourg.fr
33 3 88 11 67 68

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion